Glioz 250MG Capsule (5’s) is a pharmaceutical product containing Temozolomide, a chemotherapeutic agent primarily used in the treatment of certain types of brain tumors, including glioblastoma multiforme and anaplastic astrocytoma. Each capsule contains 250 mg of Temozolomide, which is an oral medication designed to interfere with the growth and spread of cancer cells in the body. Temozolomide works by damaging the DNA of cancer cells, ultimately leading to their death. This medication is often prescribed as part of a comprehensive treatment plan that may include surgery and radiation therapy. Glioz 250MG is typically administered in cycles, allowing for periods of rest to help the body recover from the effects of the drug. Patients taking Glioz should be closely monitored by healthcare professionals to manage any potential side effects and to assess the effectiveness of the treatment.

Temoside 250MG Tablet (5’s) is a pharmaceutical product containing the active ingredient Temozolomide, which is a chemotherapeutic agent primarily used in the treatment of certain types of brain tumors, including glioblastoma multiforme and anaplastic astrocytoma. Each tablet contains 250 mg of Temozolomide, which works by interfering with the growth and spread of cancer cells in the body. This medication is typically prescribed for patients who have undergone surgery or radiation therapy, as it can help to reduce the risk of tumor recurrence. Temozolomide is an oral medication, making it convenient for patients to take at home. The drug is absorbed in the gastrointestinal tract and is metabolized in the liver, which is essential for its effectiveness. Overall, Temoside 250MG Tablet plays a crucial role in the management of aggressive brain tumors, providing hope for improved outcomes in patients battling these challenging conditions.